Skip to main content
Clinical Trials/IRCT20160523028008N8
IRCT20160523028008N8
Completed
Phase 2

A randomized trial comparing surfactant administration using InSurE technique and the minimally invasive surfactant therapy in preterm infants at the age of 28 to 36 weeks of gestation and respiratory distress syndrome

Hamedan University of Medical Sciences0 sites112 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Hamedan University of Medical Sciences
Enrollment
112
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Gestational age of 28\-37 weeks
  • With distress syndrome
  • Requiring Fraction of inspired oxygen\>40
  • Treatment with surfactant in less than 24 hours after birth

Exclusion Criteria

  • Suffering of congenital heart abnormalities
  • APGAR score\<5
  • Suffering from any congenital disease

Outcomes

Primary Outcomes

Not specified

Similar Trials